Bibliotecas PUC-SP - Busca Integrada

Memory and Spin Injection Devices Involving Half Metals

af M. Shaughnessy, Ryan Snow, L. Damewood, C. Y. Fong
Udgivet i Journal of Nanomaterials (2011-01-01)

Embryo coculture: Sequential transfer and blastocyst freezing

af A. Bongso, C. Y. Fong, S. C. Ng, S. S. Ratnam
Udgivet i Medical Journal of Indonesia (1996-01-01)

Temporal relationships among role stress, staff burnout, and residents' behavioral problems: A 2-year longitudinal study in child care homes in Hong Kong.

af Ted C T Fong, Rainbow T H Ho, Joyce C Y Fong
Udgivet i PLoS ONE (2022-01-01)

A half-metallic half-Heusler alloy having the largest atomic-like magnetic moment at optimized lattice constant

af R. L. Zhang, L. Damewood, C. Y. Fong, L. H. Yang, R. W. Peng, C. Felser
Udgivet i AIP Advances (2016-11-01)

P562: LEMZOPARLIMAB (LEMZO) WITH VENETOCLAX (VEN) AND/OR AZACITIDINE (AZA) IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROMES (MDS): A PHASE 1B DOSE E...

af J.-Z. Hou, N. G. Daver, D. A. Stevens, T. Yamauchi, Y. Moshe, C. Y. Fong, A. Marzocchetti, R. Adamec, M. Patel, S. Lambert, K. Y. Wu, C. Röllig
Udgivet i HemaSphere (2022-06-01)

Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patien...

af Martin C S Wong, Harry H X Wang, Mandy W M Kwan, Daisy D X Zhang, Kirin Q L Liu, Sky W M Chan, Carmen K M Fan, Brian C Y Fong, Shannon T S Li, Sian M Griffiths
Udgivet i PLoS ONE (2014-01-01)

P776: A PHASE 2, OPEN-LABEL, ASCENDING DOSE STUDY OF KER-050 FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES

af S. Tan, A. Arbelaez, L. Chee, C. Y. Fong, D. Hiwase, G. Kannourakis, J. Kwan, J. Liang, A. Puliyayil, H. Rose, D. Ross, T.-C. Teh, D. Westerman, J. Wight, W. Feng, J. Lachey, A. McGinty, H. Natarajan, C. Rovaldi, S. Cooper
Udgivet i HemaSphere (2022-06-01)

P590: PRELIMINARY SAFETY AND EFFICACY OF BGB-11417, A POTENT AND SELECTIVE B-CELL LYMPHOMA 2 (BCL2) INHIBITOR, IN PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML)

af J. Shortt, S. Y. Tan, P. Cannell, T. F. Ng, C. Y. Fong, S. Ramanathan, R. Rajagopal, S. Leitch, R. Gasiorowski, C. Grove, D. Lenton, P. Tan, C. DiNardo, M. T. Ling, S. Cheng, Y. Liu, M. Co, W. Y. Chan, D. Simpson, A. H. Wei
Udgivet i HemaSphere (2022-06-01)